Correction: A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

Talaei, Ali; Hosseini, Farhad Farid; Aghili, Zahra; Akhondzadeh, Shahin; Asadpour, Elham; Mehramiz, Neema John; Forouzanfar, Fatemeh

Talaei, Ali; Hosseini, Farhad Farid; Aghili, Zahra; Akhondzadeh, Shahin; Asadpour, Elham; Mehramiz, Neema John; Forouzanfar, Fatemeh.

Afiliación

Talaei A; Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Hosseini FF; Department of Psychiatry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Aghili Z; Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Akhondzadeh S; Department of Psychiatry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Asadpour E; Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mehramiz NJ; Psychiatric Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Forouzanfar F; Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Can J Physiol Pharmacol ; 98(6): 412, 2020 06.

Article en En | MEDLINE | ID: mdl-32383985

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Can J Physiol Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google